Mauna Kea Technologies: Monthly information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
09 Agosto 2024 - 6:00PM
Business Wire
Article L233-8-II of the Commercial
Code Article 223-16 of the General Regulations of the AMF
Regulatory News:
Mauna Kea Technologies (Paris:ALMKT):
Listing: Euronext Growth Paris ISIN code: FR0010609263, Ticker:
ALMKT Website: www.maunakeatech.com
Date
Number of shares comprising
the capital in circulation
Total number of voting rights
Gross Total (1)
Net Total (2)
July 31st, 2024
65,789,997
67,069,919
67,000,313
1,100,000 new shares were issued during the month under the
PACEO financing facility, the characteristics of which are
described in the press release of May 31, 2023.
(1) The gross number of voting rights (or "theoretical" voting
rights) serves as the basis for calculating the thresholds. In
accordance with Article 223-11 of the General Regulations of the
AMF, this number is calculated on the basis of all shares carrying
voting rights, including shares without voting rights.
(2) The net number of voting rights (or voting rights
"exercisable in General Meeting") is calculated without considering
the shares with suspended voting rights. It is published for proper
public information in accordance with the AMF recommendation of
July 17, 2007.
***
About Mauna Kea Technologies Mauna Kea Technologies is a
global medical device company that manufactures and sells
Cellvizio®, the real-time in vivo cellular imaging platform. This
technology uniquely delivers in vivo cellular visualization which
enables physicians to monitor the progression of disease over time,
assess point-in-time reactions as they happen in real time,
classify indeterminate areas of concern, and guide surgical
interventions. The Cellvizio® platform is used globally across a
wide range of medical specialties and is making a transformative
change in the way physicians diagnose and treat patients. For more
information, visit www.maunakeatech.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240809277713/en/
Mauna Kea Technologies investors@maunakeatech.com
NewCap - Investor Relations Aurélie Manavarere / Thomas
Grojean +33 (0)1 44 71 94 94 maunakea@newcap.eu
Grafico Azioni Mauna Kea Technologies (EU:ALMKT)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni Mauna Kea Technologies (EU:ALMKT)
Storico
Da Mar 2024 a Mar 2025
